In this study, we focus on identifying and characterizing CD73+CD8+ T cells in the peripheral blood of patients with diffuse large B-cell lymphoma (DLBCL), aiming to elucidate their functional and phenotypic roles in tumor immunity. This evidence concerns the gene CD8A and neoplasm.